Cross Country Healthcare, Inc. provided earnings guidance for the second quarter of 2024. For the quarter, the company expected revenue in the range of $330 million to $340 million.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
14.73 USD | -0.14% | -10.24% | -34.94% |
May. 06 | Barrington Cuts Price Target on Cross Country Healthcare to $21 From $24, Maintains Outperform Rating | MT |
May. 01 | (CCRN) CROSS COUNTRY HEALTHCARE Sees Q2 EPS Range $0.10 - $0.20 | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-34.94% | 512M | |
-10.86% | 9.73B | |
-18.70% | 7.37B | |
-2.87% | 3.68B | |
-1.32% | 3.48B | |
+12.91% | 1.66B | |
+11.35% | 1.52B | |
-1.67% | 1.49B | |
-3.63% | 1.22B | |
+3.98% | 935M |
- Stock Market
- Equities
- CCRN Stock
- News Cross Country Healthcare, Inc.
- Cross Country Healthcare, Inc. Provides Earnings Guidance for the Second Quarter of 2024